HTGM logo

HTGM Cash From Investing

Annual CFI

$12.42 M
+$19.08 M+286.36%

December 31, 2022

Summary

Performance

1-Year Change

+286.36%

3-Year Change

+454.42%

5-Year Change

+278.72%

15-Year Change

+278.72%

HTGM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$24.42 M
HTGM annual cash flow from investing activities is currently -49.14% below its historical high of $24.42 million

3-Year Low

-$6.66 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HTGM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HTGM next annual earnings announcement has not yet been scheduled

OtherHTGMcash flowmetrics:

Annual CFF

$8.60 M
HTGM annual cash flow from financing activities is $8.60 million

Annual CFO

-$18.41 M
HTGM annual cash flow from operations is -$18.41 million

Annual FCF

-$18.43 M
HTGM annual free cash flow is -$18.43 million

Annual CAPEX

$23.00 K
HTGM annual capital expenditures is $23.00 thousand

Quarterly CFI

-$3.54 M
-$6.84 M-207.41%

March 31, 2023

Summary

Performance

3-Month Change

-207.41%

1-Year Change

-165.74%

3-Year Change

-189.68%

5-Year Change

+86.11%

HTGM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$10.92 M
HTGM quarterly cash flow from investing activities is currently -132.46% below its historical high of $10.92 million

3-Year Low

-$3.54 M
HTGM quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HTGM previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HTGM next earnings announcement has not yet been scheduled

OtherHTGMcash flowmetrics:

Quarterly CFF

-$1.31 M
HTGM quarterly cash flow from financing activities is -$1.31 million

Quarterly CFO

-$4.36 M
HTGM quarterly cash flow from operations is -$4.36 million

Quarterly FCF

-$4.37 M
HTGM quarterly free cash flow is -$4.37 million

Quarterly CAPEX

$6200.00
HTGM quarterly capital expenditures is $6200.00

TTM CFI

$3.48 M
-$8.94 M-71.95%

March 31, 2023

Summary

Performance

3-Month Change

-71.95%

1-Year Change

+130.48%

3-Year Change

+183.97%

5-Year Change

+199.42%

HTGM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$25.18 M
HTGM TTM cash flow from investing activities is currently -86.16% below its historical high of $25.18 million

3-Year Low

-$6.66 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HTGM previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HTGM next earnings announcement has not yet been scheduled

OtherHTGMcash flowmetrics:

TTM CFF

$1.73 M
HTGM TTM cash flow from financing activities is $1.73 million

TTM CFO

-$16.83 M
HTGM TTM cash flow from operations is -$16.83 million

TTM FCF

-$16.85 M
HTGM TTM free cash flow is -$16.85 million

TTM CAPEX

$20.90 K
HTGM TTM capital expenditures is $20.90 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

HTGM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+286.4%-165.7%+130.5%
3 y3 years+454.4%-189.7%+184.0%
5 y5 years+278.7%+86.1%+199.4%

HTGM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-153.7%-165.7%at low-71.9%-291.3%
5 y5-year-33.7%-153.7%-137.7%+538.4%-81.4%-363.0%
alltimeall time-49.1%-359.1%-132.5%+830.4%-86.2%-1181.4%

HTG Molecular Diagnostics Cash From Investing History

DateAnnualQuarterlyTTM
Mar 2023
-
-$3.54 M(-207.4%)
$3.48 M(-71.9%)
Dec 2022
$12.42 M(-286.4%)
$3.30 M(-35.8%)
$12.42 M(+4.2%)
Sep 2022
-
$5.14 M(-463.8%)
$11.92 M(+60.4%)
Jun 2022
-
-$1.41 M(-126.2%)
$7.43 M(+391.4%)
Mar 2022
-
$5.39 M(+92.7%)
$1.51 M(-122.7%)
Dec 2021
-$6.66 M(-135.6%)
$2.80 M(+328.5%)
-$6.66 M(+58.8%)
Sep 2021
-
$652.80 K(-108.9%)
-$4.20 M(-11.5%)
Jun 2021
-
-$7.33 M(+163.2%)
-$4.74 M(-139.5%)
Mar 2021
-
-$2.78 M(-152.9%)
$11.99 M(-36.0%)
Dec 2020
$18.73 M(-634.5%)
$5.27 M(+4682.7%)
$18.73 M(-304.4%)
Sep 2020
-
$110.10 K(-98.8%)
-$9.16 M(+211.7%)
Jun 2020
-
$9.40 M(+137.9%)
-$2.94 M(-29.2%)
Mar 2020
-
$3.95 M(-117.5%)
-$4.15 M(+18.4%)
Dec 2019
-$3.50 M(-84.9%)
-$22.63 M(-457.3%)
-$3.50 M(-114.5%)
Sep 2019
-
$6.33 M(-22.7%)
$24.09 M(-4.3%)
Jun 2019
-
$8.19 M(+78.2%)
$25.18 M(+264.7%)
Mar 2019
-
$4.60 M(-7.4%)
$6.90 M(-129.7%)
Dec 2018
-$23.22 M
$4.97 M(-33.1%)
-$23.22 M(-19.0%)
Sep 2018
-
$7.42 M(-173.6%)
-$28.68 M(-21.4%)
DateAnnualQuarterlyTTM
Jun 2018
-
-$10.08 M(-60.5%)
-$36.48 M(+52.7%)
Mar 2018
-
-$25.53 M(+5056.1%)
-$23.88 M(-828.3%)
Dec 2017
$3.28 M(-86.6%)
-$495.10 K(+32.7%)
$3.28 M(-68.6%)
Sep 2017
-
-$373.10 K(-114.8%)
$10.44 M(-29.8%)
Jun 2017
-
$2.51 M(+53.7%)
$14.87 M(-36.1%)
Mar 2017
-
$1.63 M(-75.5%)
$23.28 M(-4.7%)
Dec 2016
$24.42 M(-175.9%)
$6.66 M(+64.0%)
$24.42 M(+6.2%)
Sep 2016
-
$4.06 M(-62.8%)
$23.00 M(+55.0%)
Jun 2016
-
$10.92 M(+292.8%)
$14.84 M(-151.0%)
Mar 2016
-
$2.78 M(-47.0%)
-$29.06 M(-9.7%)
Dec 2015
-$32.18 M(+3652.5%)
$5.24 M(-227.7%)
-$32.18 M(-14.6%)
Sep 2015
-
-$4.10 M(-87.6%)
-$37.68 M(+11.4%)
Jun 2015
-
-$32.98 M(+9495.1%)
-$33.81 M(+3046.3%)
Mar 2015
-
-$343.70 K(+36.6%)
-$1.07 M(+25.3%)
Dec 2014
-$857.70 K(+10.3%)
-$251.70 K(+7.9%)
-$857.70 K(+41.5%)
Sep 2014
-
-$233.30 K(-5.1%)
-$606.00 K(+62.6%)
Jun 2014
-
-$245.80 K(+93.7%)
-$372.70 K(+193.7%)
Mar 2014
-
-$126.90 K
-$126.90 K
Dec 2013
-$777.80 K(+1027.2%)
-
-
Dec 2012
-$69.00 K
-
-

FAQ

  • What is HTG Molecular Diagnostics annual cash flow from investing activities?
  • What is the all time high annual CFI for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics annual CFI year-on-year change?
  • What is HTG Molecular Diagnostics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics quarterly CFI year-on-year change?
  • What is HTG Molecular Diagnostics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for HTG Molecular Diagnostics?
  • What is HTG Molecular Diagnostics TTM CFI year-on-year change?

What is HTG Molecular Diagnostics annual cash flow from investing activities?

The current annual CFI of HTGM is $12.42 M

What is the all time high annual CFI for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high annual cash flow from investing activities is $24.42 M

What is HTG Molecular Diagnostics annual CFI year-on-year change?

Over the past year, HTGM annual cash flow from investing activities has changed by +$19.08 M (+286.36%)

What is HTG Molecular Diagnostics quarterly cash flow from investing activities?

The current quarterly CFI of HTGM is -$3.54 M

What is the all time high quarterly CFI for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high quarterly cash flow from investing activities is $10.92 M

What is HTG Molecular Diagnostics quarterly CFI year-on-year change?

Over the past year, HTGM quarterly cash flow from investing activities has changed by -$8.94 M (-165.74%)

What is HTG Molecular Diagnostics TTM cash flow from investing activities?

The current TTM CFI of HTGM is $3.48 M

What is the all time high TTM CFI for HTG Molecular Diagnostics?

HTG Molecular Diagnostics all-time high TTM cash flow from investing activities is $25.18 M

What is HTG Molecular Diagnostics TTM CFI year-on-year change?

Over the past year, HTGM TTM cash flow from investing activities has changed by +$1.97 M (+130.48%)